Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.
about
Biology and disease associations of Epstein-Barr virus.EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.The Epstein-Barr virus and its association with human cancers.Effect of cyclosporin A on murine natural killer cells.Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.The mother lode of liver transplantation, with particular reference to our new journal.Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative managementSuppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosisImmunological reason for chronic ill health after infectious mononucleosis.Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disordersUnusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.Virus infections in renal transplant recipients.Cyclosporin A in clinical organ grafting. First Northern Ireland Kidney Research Fund lecture.The kissing virusImmune regulation in Epstein-Barr virus-associated diseasesAdvanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients.Epstein-Barr virus: more than 50 years old and still providing surprises.Transmission of Epstein - Barr Virus During Transplantation.Epstein-Barr virus-associated malignancies.The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP repliconICAM-1, soluble-CD23, and interleukin-10 concentrations in serum in renal-transplant recipients with Epstein-Barr virus reactivation.Human cancers and human viruses.Cyclosporin A--usefulness, risks and mechanism of action.Immune suppression with cyclosporin A-optimism and caution.Hepatitis C virus and non-Hodgkin's lymphomas.The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4Defining the unknown: molecular methods for finding new microbes.Deletion variants within the NF-kappaB activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations.Epstein-Barr (EB) virus infection in homosexual men in London.Effect of cyclosporin a on normal, mitogen-stimulated and Marek's disease virus-exposed and transformed chicken lymphoid cells.Epstein--Barr virus nuclear antigen in a non-Hodgkin's lymphoma.Cyclosporin A inhibits induction but not production of gamma interferon induced by Epstein-Barr virus.Primary gastrointestinal malignant lymphomas associated with Epstein-Barr virus after heart transplantation.
P2860
Q33772230-51989AD3-6882-44EB-8115-3368DB0A6C6DQ33860748-071702F3-46F6-4A1E-9C61-0D07A26BA0DDQ33882153-A50FEE4F-5965-4273-B0D2-3451230989E7Q33912886-20A2853D-3107-44A6-B7F5-A4F777086B45Q34235300-C82DE4B4-7D0B-4C43-B0DD-B8A23978A876Q34334755-4B86DE9B-C5AA-4560-8040-D0B8B3DD2ADCQ34359339-1288A802-14B7-4F4E-B440-F209A4055D64Q34426920-8E339E05-D8D3-4042-B737-D3914B579D8AQ34553140-6E74C9AF-6F49-4AC8-B855-C500CF4D8C86Q34993545-7016474E-8056-495F-A387-92F924292526Q35621782-DA6C6863-4926-4C23-86AC-277982A4D8FBQ35795114-FC15399C-0C81-49DD-960F-AF86745805E5Q35859094-89BC64BF-6993-4647-B679-446440C31743Q35873998-907C849A-0328-4B3C-88ED-BF6A5DABAE49Q36195236-718AED87-3581-488A-A40A-4AE6A7BF6651Q36660154-3709B22E-C9DA-492E-A019-20B65D20E743Q36660164-434135A0-1E39-405E-B6C0-2AFEF320B75EQ36660525-EF6F6077-5B79-4FEB-B6F7-0FFE3F9444DCQ36669953-717366FD-F241-4206-9A15-8DE773F4B89AQ36839720-022E6BCE-443E-42B8-AC8F-7864EB11A3D0Q37164604-06C0714F-2020-4C58-982A-89B4F06EB4CCQ38968588-17E4E096-A1C9-4074-9980-841C2195BE6AQ39045917-3B524F3A-CEE2-43B4-B93D-D3EB81883C73Q39510505-02E45BEA-065A-459B-915D-9FF25C943764Q39604954-4811F6E1-5C68-4F4E-96ED-7099A521CD77Q39811512-580AC90B-CA9F-43FD-884E-FA0B773BA27FQ40128321-FE5F00AE-799E-4429-B986-CC09909A0ECFQ40131054-4604A87D-7CE1-4B5A-8DE7-763120BA2557Q40317133-B7188199-7516-42A9-87B5-8E86F5D5086AQ41047224-BF3A312D-8F0E-46E7-ADD9-B964293B1B7BQ41223097-91DF7D6F-B78A-4B91-910C-F88D3AE51F17Q41252884-1448D1EE-0F06-4288-AF2B-2B833A7634DFQ41607034-2A34F382-6EB6-48C3-A58D-8A0DF2CEC94CQ41856318-A50A7630-D4F2-4467-9634-484E9AE37280Q45391571-058B7ACE-B74A-4A57-AEB0-54F8413C9102Q45796867-16B55E3A-2DC0-4DA0-BD99-B09D6520F355Q45838208-DA52DF81-2D0B-4703-BFD8-E39495D7993BQ45880625-6643D6AD-4160-49FE-83F9-A4E4D859B747
P2860
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@en
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@nl
type
label
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@en
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@nl
prefLabel
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@en
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@nl
P2093
P1433
P1476
Epstein Barr virus nuclear ant ...... patient with renal allograft.
@en
P2093
D H Crawford
J A Thomas
J F Moorhead
J H Thompson
O N Fernando
P304
P356
10.1016/S0140-6736(80)91800-0
P407
P577
1980-06-01T00:00:00Z